Pharmacia
This article was originally published in The Tan Sheet
Executive Summary
U.S. Rogaine sales jump 11% to $26 mil. in first quarter as hair regrowth treatment rebounds from private label competition, company says April 25. Nicorette revenues up 20% overall to $66 mil.; U.S. sales of Nicorette to GlaxoSmithKline and domestic sales of Nicotrol grow 5% to $19 mil. Consumer health segment nearly flat at $79 mil. in U.S., up 9% to $179 mil. overall. Total pharma sales increased 13% domestically and worldwide to $1.67 bil. and $3.21 bil., respectively
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning